About
Company Management
Board of Directors
Scientific Advisory Board
Timeline
Careers
Technology
Oncoprex Immunogene Therapy
Nanovesicle Delivery
Clinical Trials
Pipeline
Oncoprex Monotherapy
Erlotinib Combination
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
News
Press Releases
Blog Posts
Media Coverage
Events
Videos
Email Alerts
Contact
About
Company Management
Board of Directors
Scientific Advisory Board
Timeline
Careers
Technology
Oncoprex Immunogene Therapy
Nanovesicle Delivery
Clinical Trials
Pipeline
Oncoprex Monotherapy
Erlotinib Combination
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
News
Press Releases
Blog Posts
Media Coverage
Events
Videos
Email Alerts
Contact
© 2020 © 2020 Genprex Inc. All Rights Reserved.
About Us
Board of Directors
David E. Friedman, JD
Board Director
Robert W. Pearson, MBA
Board Director
James E. Rothman, PhD
Strategic Advisor to the Board of Directors
Brent Longnecker
Board Director
Jose A. Moreno Toscano
Board Director
William Wilson, Jr.
Board Director
